| Dr Daisy Shirk, DO | |
|
2501 N 3rd St, Harrisburg, PA 17110-1904 | |
| (717) 782-4734 | |
| (717) 782-4727 |
| Full Name | Dr Daisy Shirk |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2501 N 3rd St, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063548485 | NPI | - | NPPES |
| 01740401 | Other | PA | CBC PROVIDER ID |
| 278630 | Other | PA | HIGHMARK PROVIDER ID |
| Entity Name | The Milton S Hershey Medical Center Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710951744 PECOS PAC ID: 3870405483 Enrollment ID: O20040225000741 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
| Entity Name | Tower Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609291350 PECOS PAC ID: 7618889213 Enrollment ID: O20040311000072 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
| Entity Name | Reading Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992387518 PECOS PAC ID: 7618886490 Enrollment ID: O20040408001076 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
| Entity Name | Pennsylvania Psychiatric Institute |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1881829976 PECOS PAC ID: 3870678915 Enrollment ID: O20091112000465 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
| Entity Name | Reading Behavioral Healthcare, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750997466 PECOS PAC ID: 8527495183 Enrollment ID: O20201209001899 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daisy Shirk, DO Po Box 858, Mc A410, Hershey, PA 17033-0858 Ph: (800) 243-1455 | Dr Daisy Shirk, DO 2501 N 3rd St, Harrisburg, PA 17110-1904 Ph: (717) 782-4734 |
News Archive
Almirall, S.A. (ALM:MC) and Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced the launch of Constella® (linaclotide 290mcg capsules once daily), the first approved prescription therapy in a new class of treatments for adults suffering from moderate to severe IBS-C,(1) in Europe. Constella® is now available in Germany, the UK and Nordic countries and is expected to be launched in several other European countries in 2013.
Neurosurgeons at Thomas Jefferson University Hospital in Philadelphia are the first in the region and among the first in the nation to successfully use a new stent specifically designed to open potentially life-threatening clogged arteries in the brain, preventing a stroke.
Researchers say that children whose mothers do not enjoy their jobs also suffer increased stress.
In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.
› Verified 1 days ago
Dr. Valentyna Honchar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4250 Crums Mill Rd Ste 102, Harrisburg, PA 17112 Phone: 717-649-0211 Fax: 206-895-7032 | |
Dr. Yassir Osama Mahgoub, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2501 North Third St, Harrisburg, PA 17110 Phone: 717-782-6420 Fax: 717-782-4727 | |
Rahat Taswir, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2209 Forest Hills Dr, Suite 19, Harrisburg, PA 17112 Phone: 717-540-4420 Fax: 717-540-4427 | |
Nuzhat Kausar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2595 Interstate Dr, Suite 103, Harrisburg, PA 17110 Phone: 800-370-3651 Fax: 860-510-0020 | |
Ray E Sharretts, DO Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 409 S 2nd St, Suite 3f, Harrisburg, PA 17104 Phone: 717-123-0345 Fax: 717-230-3411 | |
Paul A Conti, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 307 S Front St, Harrisburg, PA 17104 Phone: 717-221-6200 Fax: 717-221-6208 |